The Critical Link Between Cost, Quality, and Outcomes (CQO) and Unique Device Identification (UDI) White Paper

By AHRMM

In an effort to capture broader insights on UDI adoption from across the health care field, AHRMM, with participation by the FDA, held LUC Data Quality Workshops during four conferences in 2017. During these workshops, conference attendees had the opportunity to voice their opinions on the state of UDI data quality, hurdles to UDI adoption and what recommended practices are necessary for providers and suppliers to effectively capture the UDI and use it in meaningful ways.  

A clear message has emerged from health care stakeholders – the only way to drive greater UDI adoption across the health care field is for the individuals and groups engaged in UDI efforts to collaborate, share their experiences, and learn from each other. In this paper, we leverage these collective insights to present challenges faced by providers and manufacturers today with regards to UDI adoption, and highlight potential solutions that have emerged from the work of the LUC and other health care participants.

 

Related Resources

Advisory
Final Regulations on Taxable Medical Devices
The final regulations that provide guidance on the excise tax imposed on the sale of certain medical devices, enacted by the Health Care and Educ
Letter/Comment
The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Fo
AHRMM Cost, Quality and Outcomes (CQO) Movement
The AHRMM Cost, Quality, and Outcomes (CQO) Movement frames the critical role supply chain professionals play in driving high quality care, at a more…